miR-143 regulates hexokinase 2 expression in cancer cells

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Tumor cells exhibit increased glycolysis (the Warburg effect) to meet energy and biosynthetic demands for rapid proliferation.
• Hexokinase 2 (HK2) is frequently overexpressed in various human tumors, contributing to this altered glucose metabolism.
• The regulatory mechanisms of HK2 expression in cancer, particularly the role of microRNAs, remain largely unexplored.

Purpose of the Study:

• To investigate the potential role of microRNAs (miRNAs) in regulating hexokinase 2 (HK2) expression in cancer.
• To identify specific miRNAs that target HK2 and elucidate the underlying molecular mechanism.

Main Methods:

• Bioinformatic analysis to identify potential miRNA binding sites in the HK2 3'-untranslated region (3'UTR).
• Experimental validation using cell lines (primary keratinocytes and HNSCC-derived) to assess the effect of miR-143 on HK2 expression.
• Correlation analysis of miR-143 and HK2 expression levels in cell lines and primary tumor samples.

Main Results:

• miR-143 directly inhibits HK2 expression by binding to a conserved recognition motif in the HK2 mRNA 3'UTR.
• This inhibitory effect of miR-143 on HK2 was confirmed in both primary keratinocytes and HNSCC cell lines.
• A significant inverse correlation between miR-143 levels and HK2 expression was observed in HNSCC cell lines and primary tumors.
• Additionally, miR-138 was found to target HK1, suggesting a broader miRNA-mediated regulation of hexokinase isoforms.

Conclusions:

• Unveils a novel miRNA-dependent regulatory mechanism for hexokinase expression, specifically miR-143 targeting HK2.
• This finding highlights the importance of miRNAs in controlling glucose metabolism in cancer cells.
• Suggests that targeting miRNA-HK2 interactions could represent a potential therapeutic strategy for cancers exhibiting altered glucose metabolism.